Trials / Completed
CompletedNCT02255734
Bioequivalence of Two Formulations of Acyclovir
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Bioequivalence of two formulations of Acyclovir (Acyclovir Lyophilized I.V. infusion 250mg) after Intravenous Infusion in Healthy Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acyclovir |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-04-01
- First posted
- 2014-10-03
- Last updated
- 2014-10-03
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02255734. Inclusion in this directory is not an endorsement.